Peng Li

20.6k citations

408 papers · 13.3k indexed · 4 hit papers · h-index 56

Impact in

Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Molecular Biology top 0.5%
- Inflammasome and immune disorders
- RNA modifications and cancer

Papers in

Immunology 85
- Immune Cell Function and Interaction 37
- Immunotherapy and Immune Responses 19
- T-cell and B-cell Immunology 15
Complementary and alternative medicine 32
- Traditional Chinese Medicine Analysis 15

Co-authors: John C. Longhurst Stephanie C. Tjen‐A‐Looi Pentao Liu Shen Yon Toh Le Qin Xinru Wei Guoyao Wu Stephen C. Bunnell
Journals: Scientific Reports (7 papers)Oncotarget (7 papers)Nature Communications (6 papers)Frontiers in Immunology (5 papers)PLoS ONE (5 papers)
Partner nations: China United States Hong Kong

In The Last Decade

Peng Li

392 papers receiving 13.1k citations

Hit Papers

align trajectories log scale

YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis 2020 · 298 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Cancer Cell
2020 PLoS Biology
2019 Immunity
2018 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Peng Li

Since Specialization

Citations

This map shows the geographic impact of Peng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Li more than expected).

Fields of papers citing papers by Peng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Li. The network helps show where Peng Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Peng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peng Li Line = papers co-authored together Peng Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The burden of rheumatoid arthritis in China from 1990 to 2019 and projections to 2030 Public Health ·Yue Zhou, Xiaomei Luo, Peng Li, Xiaohui Liu, Jie Li, Li Su, Xueyan Gu, Jianhua Ma	2025	0
2	Phylogenomic analysis uncovers an unexpected capacity for the biosynthesis of secondary metabolites in Pseudoalteromonas European Journal of Medicinal Chemistry ·Jingxuan Wang, Peng Li, Di Xue, Hongmei Lü, Huamao Wei, Shuai Zhi, David P. Fewer, Shan He, Liwei Liu	2024	1
3	CIDEC/FSP27 exacerbates obesity-related abdominal aortic aneurysm by promoting perivascular adipose tissue inflammation PubMed ·Qing Zhu, Da Luo, Yining Li, Liyang Yu, Zixuan Zhang, Feng Ouyang, Liangkui Li, Manxi Lu, Changyong Hu, Yinuo Dong, Chengxin Ma, Yan Liang, Tong‐Jin Zhao, Feng‐Jung Chen, Peng Li, Tianshu Yang	2024	2
4	Integrated Trap‐Adsorption‐Catalysis Nanoreactor for Shuttle‐Free Aqueous Zinc‐Iodide Batteries Advanced Functional Materials ·Lingfeng Zhu, Xinwei Guan, Yang Fu, Zhenfang Zhang, Yitong Li, Qi Mai, Congcong Zhang, Zhilong Yuan, Ye Wang, Peng Li, Hui Li, Dawei Su, Baohua Jia, Hai Yu, Yifei Sun, Tianyi Ma	2024	33
5	Integrated Trap‐Adsorption‐Catalysis Nanoreactor for Shuttle‐Free Aqueous Zinc‐Iodide Batteries (Adv. Funct. Mater. 48/2024) Advanced Functional Materials ·Lingfeng Zhu, Xinwei Guan, Yang Fu, Zhenfang Zhang, Yitong Li, Qi Mai, Congcong Zhang, Zhilong Yuan, Ye Wang, Peng Li, Hui Li, Dawei Su, Baohua Jia, Hai Yu, Yifei Sun, Tianyi Ma	2024	2
6	Potentials of dietary fiber and polyphenols in whole grain wheat flour to release the liver function and intestinal tract injury in lead-induced mice International Journal of Biological Macromolecules ·Jiayu Zheng, Tianhang Huang, Fengjiao Fan, Xiaoyi Jiang, Peng Li, Jian Ding, Xinyang Sun, Ziqian Li, Yong Fang	2024	2
7	The impact of patient- and family-centered care interventions on intensive care unit outcomes: a meta-analysis of randomized controlled trials Brazilian Journal of Anesthesiology (English Edition) ·Yang‐Yang Lv, Peng Li, Ronghui Li, Ting Zhang, Keke Cai	2024	2
8	Composite-structure oleogels constructed by glycerol monolaurate and whey protein isolate: Preparation, characterization and in vitro digestion Food Chemistry ·Shijie Zheng, Yang Li, Qinbo Jiang, Shahzad Farooq, Jiawen Li, Zhe Cai, Peng Li, Hui Zhang, Feng Zhang	2024	10
9	c-Met is a chimeric antigen receptor T-cell target for treating recurrent nasopharyngeal carcinoma Cytotherapy ·Qingyi Huo, Jiang Lv, Jianzhong Zhang, Haiqiong Huang, Huayong Hu, Yaoxin Zhao, Xinrui Zhang, Yingqi Wang, Yiyi Zhou, Junchao Qiu, Yanmei Ye, Aiqun Huang, Yanhong Chen, Le Qin, Dajiang Qin, Peng Li, Gang Cai	2023	5
10	A 2-decade bibliometric analysis of epigenetics of cardiovascular disease: from past to present Clinical Epigenetics ·Yukang Mao, Kun Zhao, Nannan Chen, Qiang-Qiang Fu, Yimeng Zhou, Chuiyu Kong, Peng Li, Chuanxi Yang	2023	9
11	Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells Nature Communications ·Yixi Zhang, Hongyu Fang, Guocan Wang, Guangxun Yuan, Ruo‐Yu Dong, Jijun Luo, Yu Lyu, Yajie Wang, Peng Li, Chun Zhou, Weiwei Yin, Haowen Xiao, Jie Sun, Xun Zeng	2023	16
12	Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy SHILAP Revista de lepidopterología ·Miaomiao Gong, Han Meng, Dengxu Tan, Peng Li, Jing Qin, Qingling An, Changhong Shi, Jiaze An	2023	5
13	Identification of potential quality markers of Zishen Yutai pill based on spectrum–effect relationship analysis Frontiers in Pharmacology ·Sijia Wu, Qiuling Huang, Feiya Sheng, Lele Zhang, Liang Zou, Lele Yang, Jiliang Cao, Xiufei Pang, Na Ning, Peng Li	2023	2
14	Assessment of chimeric antigen receptor T cytotoxicity by droplet microfluidics in vitro PubMed ·Kuan Un Wong, Jingxuan Shi, Peng Li, Haitao Wang, Yanwei Jia, Chu‐Xia Deng, Lianmei Jiang, Ada Hang‐Heng Wong	2022	4
15	Disruption of SND1–MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells In Vitro and In Vivo Molecular Cancer Therapeutics ·Peng Li, Yunjiao He, Teng Chen, Kit-Ying Choy, Tsun Sing Chow, Iris L. K. Wong, Xinqing Yang, Wenqin Sun, Xiaochun Su, Tak Hang Chan, Larry M. C. Chow	2020	13
16	Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade Proceedings of the National Academy of Sciences ·Rohit R. Jadhav, Se Jin Im, Bin Hu, Masao Hashimoto, Peng Li, Jian-Xin Lin, Warren J. Leonard, William J. Greenleaf, Rafi Ahmed, Jörg J. Goronzy	2019	154
17	SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival Nature Communications ·Hexiu Su, Juncheng Hu, Liang Huang, Yang Yang, Morgan Thénoz, Anna Kuchmiy, Yufeng Hu, Peng Li, Hui Feng, Yu Zhou, Tom Taghon, Pieter Van Vlierberghe, Guoliang Qing, Zhichao Chen, Hudan Liu	2018	24
18	GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome Cancer Research ·Peng Li, Evan Wuthrick, Jeffrey A. Rappaport, Crystal Kraft, Jieru E. Lin, Glen P. Marszalowicz, Adam E. Snook, Tingting Zhan, Terry Hyslop, Scott A. Waldman	2017	12
19	Stabilization of Notch1 by the Hsp90 Chaperone is Crucial for T-Cell Leukemogenesis Clinical Cancer Research ·Zhaojing Wang, Yufeng Hu, Daibiao Xiao, Jingchao Wang, Chuntao Liu, Yisheng Xu, Xiaomeng Shi, Peng Jiang, Liang Huang, Peng Li, Hudan Liu, Guoliang Qing	2017	30
20	Reprogramming of T Cells to Natural Killer–Like Cells upon Bcl11b Deletion Science ·Peng Li, Shannon Burke, Juexuan Wang, Xiongfeng Chen, Mariaestela Ortiz, Song-Choon Lee, Dong Lu, Lia S. Campos, David Goulding, Bee Ling Ng, Gordon Dougan, Brian J.P. Huntly, Berthold Göttgens, Nancy A. Jenkins, Neal G. Copeland, Francesco Colucci, Pentao Liu	2010	267

About Peng Li

Peng Li is a scholar working on Immunology, Complementary and alternative medicine, Molecular Biology, Oncology and Cancer Research, having authored 408 papers that have together received 13.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (37 papers), CAR-T cell therapy research (35 papers), RNA modifications and cancer (21 papers), Immunotherapy and Immune Responses (19 papers), Adipose Tissue and Metabolism (17 papers), Cancer-related gene regulation (17 papers), Traditional Chinese Medicine Analysis (15 papers) and T-cell and B-cell Immunology (15 papers). The work is most often cited by research in Immunology (2.7k citations), Molecular Biology (6.3k citations), Oncology (2.4k citations), Complementary and alternative medicine (716 citations) and Biochemistry (608 citations). Peng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include John C. Longhurst, Stephanie C. Tjen‐A‐Looi, Pentao Liu, Shen Yon Toh, Le Qin, Xinru Wei, Guoyao Wu, Stephen C. Bunnell, Yunxin Lai and Anthony Rongvaux. Their work appears in journals such as Scientific Reports, Oncotarget, Nature Communications, Frontiers in Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact